Tag: safety reporting timelines

Safety Monitoring in Pediatric and Geriatric Clinical Trials

Posted on digi By digi

Safety Monitoring in Pediatric and Geriatric Clinical Trials Comprehensive Safety Monitoring for Pediatric and Geriatric Clinical Trials Introduction to Safety Monitoring in Age-Specific Trials Safety monitoring in clinical trials is essential to protect participants and ensure data integrity. In pediatric and geriatric populations, the stakes are even higher due to physiological differences, higher vulnerability to…

Read More “Safety Monitoring in Pediatric and Geriatric Clinical Trials” »

Age-Specific Protocol Design, Pediatric and Geriatric Clinical Trials

Understanding Adverse Events vs Serious Adverse Events in Clinical Trials

Posted on digi By digi

Understanding Adverse Events vs Serious Adverse Events in Clinical Trials Distinguishing Adverse Events and Serious Adverse Events in Clinical Trials Clinical trials are designed to assess the safety and efficacy of investigational products, making the monitoring and reporting of adverse events (AEs) and serious adverse events (SAEs) a cornerstone of clinical research. Although these terms…

Read More “Understanding Adverse Events vs Serious Adverse Events in Clinical Trials” »

Adverse Event Reporting, Safety Reporting and Pharmacovigilance

Safety Monitoring Requirements in ASEAN Member States: A Clinical Trial Guide

Posted on digi By digi

Safety Monitoring Requirements in ASEAN Member States: A Clinical Trial Guide Guide to Safety Monitoring Standards in ASEAN Countries for Clinical Trials Ensuring participant safety is paramount in clinical trials, and this obligation becomes more complex when conducting studies across multiple jurisdictions like the ASEAN region. Each ASEAN member state has distinct requirements for safety…

Read More “Safety Monitoring Requirements in ASEAN Member States: A Clinical Trial Guide” »

ASEAN Guidelines, Regulatory Guidelines